As of 2025-07-12, the Intrinsic Value of Design Therapeutics Inc (DSGN) is -5.02 USD. This DSGN valuation is based on the model Peter Lynch Fair Value. With the current market price of 4.04 USD, the upside of Design Therapeutics Inc is -224.26%.
Based on its market price of 4.04 USD and our intrinsic valuation, Design Therapeutics Inc (DSGN) is overvalued by 224.26%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -5.02 - -5.02 | -5.02 | -224.26% |
| P/E | (13.45) - (19.00) | (13.76) | -440.5% |
| DDM - Stable | (8.61) - (39.84) | (24.23) | -699.7% |
| DDM - Multi | (6.73) - (25.27) | (10.76) | -366.2% |
| Market Cap (mil) | 229.35 |
| Beta | 1.27 |
| Outstanding shares (mil) | 56.77 |
| Enterprise Value (mil) | 215.68 |
| Market risk premium | 4.60% |
| Cost of Equity | 9.21% |
| Cost of Debt | 5.00% |
| WACC | 6.55% |